Metabolic Syndrome and Outcomes after Renal Intervention
Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown th...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.4061/2011/781035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832563624016609280 |
---|---|
author | Daynene Vykoukal Mark G. Davies |
author_facet | Daynene Vykoukal Mark G. Davies |
author_sort | Daynene Vykoukal |
collection | DOAJ |
description | Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown that increased body mass index as well as insulin resistance and increased fasting insulin levels is associated with chronic kidney disease, even after adjustment for related disorders. Metabolic syndrome appears to be a risk factor for chronic kidney disease, likely due to the combination of dysglycemia and high blood pressure. Metabolic syndrome is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. Metabolic syndrome is associated with inferior early outcomes for dialysis access procedures. |
format | Article |
id | doaj-art-2ad9bae441aa4d94815e5d6546685636 |
institution | Kabale University |
issn | 2090-0597 |
language | English |
publishDate | 2011-01-01 |
publisher | Wiley |
record_format | Article |
series | Cardiology Research and Practice |
spelling | doaj-art-2ad9bae441aa4d94815e5d65466856362025-02-03T01:12:55ZengWileyCardiology Research and Practice2090-05972011-01-01201110.4061/2011/781035781035Metabolic Syndrome and Outcomes after Renal InterventionDaynene Vykoukal0Mark G. Davies1Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin, Smith Tower, Suite 1401, Houston, TX 77030, USADepartment of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin, Smith Tower, Suite 1401, Houston, TX 77030, USAMetabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity. Multiple observational studies have consistently shown that increased body mass index as well as insulin resistance and increased fasting insulin levels is associated with chronic kidney disease, even after adjustment for related disorders. Metabolic syndrome appears to be a risk factor for chronic kidney disease, likely due to the combination of dysglycemia and high blood pressure. Metabolic syndrome is associated with markedly reduced renal clinical benefit and increased progression to hemodialysis following endovascular intervention for atherosclerotic renal artery stenosis. Metabolic syndrome is associated with inferior early outcomes for dialysis access procedures.http://dx.doi.org/10.4061/2011/781035 |
spellingShingle | Daynene Vykoukal Mark G. Davies Metabolic Syndrome and Outcomes after Renal Intervention Cardiology Research and Practice |
title | Metabolic Syndrome and Outcomes after Renal Intervention |
title_full | Metabolic Syndrome and Outcomes after Renal Intervention |
title_fullStr | Metabolic Syndrome and Outcomes after Renal Intervention |
title_full_unstemmed | Metabolic Syndrome and Outcomes after Renal Intervention |
title_short | Metabolic Syndrome and Outcomes after Renal Intervention |
title_sort | metabolic syndrome and outcomes after renal intervention |
url | http://dx.doi.org/10.4061/2011/781035 |
work_keys_str_mv | AT daynenevykoukal metabolicsyndromeandoutcomesafterrenalintervention AT markgdavies metabolicsyndromeandoutcomesafterrenalintervention |